Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tacrolimus as Add-on for Moderate to Severe Asthma
NCT00189722Phase 2Completed
- Sponsor
- Astellas Pharma
- Primary completion
- Jul 2005
- Modality
- RNA-Targeting Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tacrolimus in asthma, sponsored by Astellas Pharma. Status: completed.
02
Drugs
tacrolimus
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00189722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189722.